Alzheimer's drug fails key vote
Biogen Inc.'s experimental Alzheimer's disease therapy failed to gain support from a panel of U.S. Food and Drug Administration advisers on Friday, putting the drug at a cr…
Biogen Inc.'s experimental Alzheimer's disease therapy failed to gain support from a panel of U.S. Food and Drug Administration advisers on Friday, putting the drug at a cr…